In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Takeda’s Strategic Run Up To Nycomed

Executive Summary

With the acquisition of Nycomed, Takeda’s long-standing strategy for becoming a world-class pharma has come into focus. The company spent much of the past decade building up its pipeline, globalizing R&D and importing Western staff, assets, platforms and processes. It also began a hectic period of M&A unparalleled among Japanese companies, culminating in 2011 with its acquisition of Nycomed. Now its focus will need to shift from big acquisitions and organizational makeover to execution.

Advertisement

Related Content

The Art Of Cutting Costs Without Jeopardizing Growth: An Interview With Merck Serono's Belén Garijo
Bringing Urgency And Focus To Takeda: An Interview With Tachi Yamada
Takeda’s Tachi Yamada Discusses The Late-Stage Pipeline: An Interview At PSA 2013
Forest’s Respiratory Pipeline: Can It Open The Revenue Airway?
With URL, Takeda Looks To Become U.S. Gout Therapy Provider Of Choice
With Nycomed, Takeda Satifies Both Strategic And Financial Objectives
Takeda Finally Reveals €9.6B Nycomed Acquisition; Sheds Dermatology Business, But Otherwise Set On Retention
Forest Acquires U.S. Rights To Nycomed's Oral COPD Drug Daxas
Takeda's Global Ambition
Takeda Buys Abbott’s Stake In TAP Joint Venture

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV003879

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel